| Principal Investigator: | Najma Khalid |
| Co-Investigators: | Emily White, Noel Weiss, Nicole Urban, Meg Mandelson |
| Funder: | National Institute of Health and National Cancer Institute |
| Project Dates: | 1988 – 1993 |
Abstract:
- Evaluate whether the use of exogenous postmenopausal hormones is associated with the risk of interval breast cancer vs. screen detected cancer.
- Examine whether the formulation and dose of HRT are associated with the risk of interval breast cancer.
- Evaluate whether HRT is related to tumor aggressiveness and whether this association explains, in part, any association of HRT with the risk of interval breast cancer.
- Evaluate whether HRT is related to mammographic breast density and whether this association explains in part, any association of HRT with the risk of interval breast cancer.
Publications:
Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 1999 Dec 1;91(23):2020-8. Abstract.